InvestorsHub Logo
Followers 48
Posts 2740
Boards Moderated 0
Alias Born 02/06/2017

Re: abeta post# 668899

Wednesday, 01/31/2024 10:52:46 AM

Wednesday, January 31, 2024 10:52:46 AM

Post# of 689507
Glioblastoma studies show promise
By University Communications, Friday, January 26th, 2024

(DCVax-L trial is mentioned)

Personalized immune therapy

A November 2022 study found that a newpersonalized immune therapyfrom Northwest Biotherapeutics improved survival time for many patients. Dr. Matt Ewend, Van L. Weatherspoon Jr. Eminent Distinguished Professor of Neurosurgery and Lineberger member, led the trial site at the N.C. Basnight Cancer Hospital and co-authored the study report.



https://www.unc.edu/discover/glioblastoma-studies-show-promise/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News